NASDAQ: GHGuardant Health Inc Stock Ownership - Who owns Guardant Health?
Insider buying vs selling
Have Guardant Health Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Medina Manuel Hidalgo | Director | 2025-09-12 | 2,165 | $54.16 | $117.25kSell |
| Helmy Eltoukhy | Co-Chief Executive Officer | 2025-09-09 | 5,277 | $59.94 | $316.28kSell |
| Helmy Eltoukhy | Co-Chief Executive Officer | 2025-09-09 | 294,723 | $59.45 | $17.52MSell |
| Meghan V. Joyce | Director | 2025-09-02 | 100 | $65.84 | $6.58kSell |
| John G. Saia | Chief Legal Officer | 2025-09-01 | 139 | $67.42 | $9.37kSell |
| Darya Chudova | Chief Technology Officer | 2025-09-01 | 161 | $67.42 | $10.85kSell |
| Kumud Kalia | Chief Information Officer | 2025-09-01 | 361 | $67.42 | $24.34kSell |
| Kumud Kalia | Chief Information Officer | 2025-08-21 | 2,000 | $61.76 | $123.51kSell |
| Musa Tariq | Director | 2025-08-19 | 116 | $59.02 | $6.85kSell |
| Myrtle S. Potter | Director | 2025-08-19 | 26 | $59.02 | $1.53kSell |
GH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GH insiders and whales buy or sell their stock.
GH Shareholders
What type of owners hold Guardant Health Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Softbank Vision Fund Aiv M1 LP | 20.70% | 25,816,470 | $1.42B | Insider |
| Svf Bluebird Cayman Ltd | 16.90% | 21,075,920 | $1.16B | Insider |
| Vanguard Group Inc | 9.76% | 12,168,020 | $667.96M | Institution |
| Blackrock Inc | 8.80% | 10,979,470 | $602.72M | Institution |
| Amirali Talasaz | 4.53% | 5,643,838 | $309.82M | Insider |
| Capital International Investors | 3.99% | 4,976,458 | $273.18M | Institution |
| Baillie Gifford Co | 3.86% | 4,809,786 | $264.03M | Institution |
| Deep Track Capital LP | 3.41% | 4,250,000 | $233.30M | Institution |
| Invesco Ltd | 2.85% | 3,558,501 | $195.34M | Institution |
| Eventide Asset Management LLC | 2.77% | 3,458,963 | $189.88M | Institution |
GH vs Diagnostic & Research Stocks
Guardant Health Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.